Stem Cell Researcher Dr. Craig Jordan to Speak at CHI's Cancer Stem Cells in Oncology Symposium

Jan. 6, 2012 - PRLog -- Cambridge Healthtech Institute (CHI) announces the addition of Craig T. Jordan, Ph.D., Professor of Medicine, James P. Wilmot Cancer Center, University of Rochester School of Medicine, as a speaker at the Targeting Cancer Stem Cells in Oncology: The Challenge of Drug Development against a Moving Target symposium to be held on February 19-20, 2012 at the San Francisco InterContinental Hotel.  This symposium is part of the Molecular Medicine Tri-Conference.

Dr. Jordan will present on Characterization and Targeting of Human Leukemia Stem Cells on Sunday, Feburary 18 at 8:50 a.m. Human leukemia stem cells (LSCs) are preferentially resistant to many forms of conventional therapy and represent a significant challenge to the development of improved regimens for leukemia patients. We have demonstrated that certain classes of compounds are able to direct target LSCs, while also sparing normal hematopoietic stem and progenitor cells.  Agents capable of eradicating LSCs function via a multiparameter mechanism in which pathways related to oxidative balance, stress response, and survival are simultaneously modulated.  Data will be presented describing such pathways and strategies to create strategies for therapeutic targeting of human LSCs.

Additional presentations will cover:

- Relevance and Reality: The Promise of Cancer Stem Cells
- Developing In Vitro Screening Assays for Therapeutic Development
- EMT & Treatment Resistance
- Isolation & Characterization of Cancer Stem Cells
- From Therapeutic Discovery to the Clinic
- Emerging Cancer Stem Cell Therapeutic Programs

Advance registration discounts are available until January 13, 2012. To view the agenda and to register, please visit http://www.TriConference.com/targeting-cancer-stem-cells

To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com